MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Excessive daytime sleepiness(EDS)"

  • 2022 International Congress

    Sleep in adult-onset idiopathic focal cervical dystonia (AOIFCD): an evaluation using self-reported and accelerometer derived measures

    G. Bailey, M. Wadon, S. Komarzynski, K. Szewczyk-Krolikowski, A. Moore, C. Matthews, EH. Davies, K. Peall (Cardiff, United Kingdom)

    Objective: To identify sleep disturbances amongst individuals diagnosed with AOIFCD using wrist-worn accelerometers and subjective electronic questionnaires. Background: Up to 70% of individuals diagnosed with…
  • 2022 International Congress

    sleep disturbance and wakefulness in parkinson’s disease

    A. Tohirjonova, м. Tohirjonov (Tashkent, Uzbekistan)

    Objective: a complete study of sleep disorders and their adequate treatment Background: Sleep and wake disturbances are the second most common non-motor symptom of Parkinson's…
  • 2022 International Congress

    Prevalence, clinical and neuropsychiatric aspects of Sleep Disorders in Parkinson’s disease: a meta-analysis

    G. Maggi, F. Cerciello, I. Obeso, G. Santangelo (Caserta, Italy)

    Objective: The present meta-analysis aims to provide a reliable estimate of the prevalence and associated clinical and neuropsychiatric aspects of the most frequent sleep disorders…
  • 2022 International Congress

    Prevalence of sleep disorders in Parkinson’s disease patients at a Brazilian movement disorders center in 2022

    L. Castanheira, C. Lobo, I. Oliveira, L. de Almeida, G. Valença (Salvador, Brazil)

    Objective: To describe the prevalence of the main sleep disorders in patients with Parkinson's disease at a referral outpatient clinic for movement disorders. Background: Parkinson's…
  • MDS Virtual Congress 2021

    Safinamide Improves Sleep and Daytime Sleepiness in Parkinson´s Disease. Results from the SAFINONMOTOR Study

    I. Cabo López, C. Labandeira Guerra, R. Yáñez Baña, MI. Cimas Hernando, JM. Paz González, MG. Alonso Losada, MJ. González Palmás, C. Martínez Miró, D. Santos García (Pontevedra, Spain)

    Objective: Our aim was to analyze the effectiveness of safinamide on sleep in Parkinson´s disease (PD) patients from the SAFINONMOTOR (an open-label study of the…
  • MDS Virtual Congress 2021

    Improved Excessive Daytime Sleepiness with Selegiline in patients with Parkinson’s Disease: An Open Trial

    JR. Zhang, JP. Chen, J. Li, J. Li, CJ. Mao, CF. Liu (Suzhou, China)

    Objective: This study, an open-labeled trial, was aimed to assess the efficacy and safety of selegiline on the treatment of EDS in PD patients. Background: Excessive Daytime…
  • MDS Virtual Congress 2021

    Improvement of excessive daytime sleepiness with low frequency repetitive transcranial magnetic stimulation in Parkinson’s disease: a preliminary sham-controlled study

    S. Zhuang, JJ. Wu, X. Gu, LX. Wang, XY. Zhang, CJ. Mao, J. Chen, CF. Liu (Suzhou, China)

    Objective: To explore whether repetitive transcranial magnetic stimulation (rTMS) can improve excessive daytime sleepiness (EDS) in individuals with Parkinson’s disease (PD). Background: Excessive daytime sleepiness…
  • MDS Virtual Congress 2020

    Association Between Fatigue, Depression and Sleep Disorders in People with Parkinson’s Disease

    G. Xavier-Souza, I. Alves, A. Mendoza, L. Almeida, G. Valença (Salvador, Brazil)

    Objective: To identify the association between fatigue, sleep disorders and depression in people with Parkinson’s disease (PD). Background: Fatigue is one of the most prevalent…
  • MDS Virtual Congress 2020

    Excessive Daytime Sleepiness in Parkinson’s disease and Narcolepsy Genetic Risk Allele HLA DQB1*0602

    S. Azher, E. Molho, A. Hahn, O. Adam (Albany, NY, USA)

    Objective: To determine whether narcolepsy risk allele HLA DQB1*0602 is associated with excessive daytime sleepiness (EDS) in patients with Parkinson's disease (PD) on dopaminergic agents.…
  • MDS Virtual Congress 2020

    Prevalence of apathy in Indian patients with Parkinson’s disease and its correlation with nigrosomal imaging

    R. Kandadai, P. Reddy, A. Arora, S. Meka, T. Syed, S. Turaga, R. Borgohain (Hyderabad, India)

    Objective: To assess the prevalence of apathy in patients with patients with Parkinson's disease and to correlate it with nigrosomal imaging in a subset of…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley